Intact Investment Management Inc. acquired a new stake in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 460 shares of the aerospace company’s stock, valued at approximately $75,000. Other hedge funds also recently modified their holdings of […]

Intact Investment Management Inc. purchased a new position in shares of Globe Life Inc. (NYSE:GL – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 690 shares of the company’s stock, valued at approximately $73,000. Other hedge funds have also made changes […]

Intact Investment Management Inc. bought a new position in shares of Newmont Co. (NYSE:NEM – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,400 shares of the basic materials company’s stock, valued at approximately $75,000. Other hedge funds have […]

Intact Investment Management Inc. purchased a new position in Simon Property Group, Inc. (NYSE:SPG – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 440 shares of the real estate investment trust’s stock, valued at approximately $74,000. Other institutional investors also […]

Intact Investment Management Inc. purchased a new stake in shares of Brookfield Business Partners L.P. (NYSE:BBU – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,900 shares of the business services provider’s stock, valued at approximately $45,000. Other institutional investors and […]

Intact Investment Management Inc. lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 70.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 1,040 shares of the biotechnology company’s stock after selling 2,490 shares during the period. Intact Investment Management Inc.’s holdings in Biogen […]

Leidos (NYSE:LDOS – Free Report) had its price objective boosted by Barclays from $165.00 to $210.00 in a research note issued to investors on Monday, Benzinga reports. They currently have an overweight rating on the aerospace company’s stock. Other equities research analysts have also recently issued research reports about the company. Royal Bank of Canada […]

Madison Square Garden Sports (NYSE:MSGS – Get Free Report) had its target price raised by research analysts at Macquarie from $235.00 to $240.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Macquarie’s target price suggests a potential upside of 10.16% […]

Chevron (NYSE:CVX – Free Report) had its price target hoisted by Barclays from $168.00 to $174.00 in a research report sent to investors on Monday, Benzinga reports. The firm currently has an overweight rating on the oil and gas company’s stock. Several other equities research analysts also recently weighed in on CVX. Royal Bank of […]